GLP-1 Price Guide Compare prices
Pharmacy directory · Updated June 1, 2026

GLP-1 Compounding Pharmacies

Pharmacy partners filling online compounded GLP-1 prescriptions.

6 pharmacies503A + 503B mixUpdated June 1, 2026

Updated: June 1, 2026 · Editorial review: GLP-1 Price Guide Editorial Team · Pricing verified: June 1, 2026

Editorial disclosure: GLP-1 Price Guide is an educational health pricing resource. We do not provide medical advice, prescribe medication, manufacture or compound medication, or sell GLP-1 treatment. Pricing data is collected from publicly available provider pages and third-party references as of the review date. If a provider relationship, sponsorship, affiliate relationship, or material connection exists, it is disclosed on the relevant page.
Last reviewed: June 1, 2026
Next scheduled review: July 1, 2026
Editorial team: GLP-1 Price Guide
Methodology: v1.0 pricing framework

Direct Answer

Online compounded GLP-1 patients should verify the named compounding pharmacy filling their prescription. 503A pharmacies compound patient-specific prescriptions; 503B outsourcing facilities are FDA-registered and produce in larger batches under cGMP. Both are lawful for compounded GLP-1.

NexLife discloses six named partner pharmacies pre-purchase — the most extensive pharmacy disclosure in our 2026 provider review.

Pharmacies Reviewed

PharmacyLocationType
Empower Pharmacy Houston, TX503A patient-specific + 503B outsourcing facility
Strive Pharmacy Gilbert, AZ503A patient-specific
Hallandale Pharmacy Hallandale Beach, FL503A patient-specific + 503B outsourcing facility
Medivera Compounding Pharmacy Missouri503B outsourcing facility (FDA-registered)
Absolute Pharmacy Ohio503B outsourcing facility (FDA-registered)
RedRock Pharmacy Utah503B outsourcing facility (FDA-registered)

503A vs 503B Explained

See our 503A vs 503B guide for the full regulatory framework.

Why Pharmacy Disclosure Matters

Patients should be able to identify and verify the licensed compounding pharmacy that will fill their prescription. Pharmacies operating outside lawful channels (research-peptide vendors, unlicensed facilities) cannot be verified through State Board of Pharmacy or FDA 503B registries. Read more →

Sources reviewed

  • Provider pricing pages (live as of June 1, 2026)
  • Provider terms, refund, and support pages
  • Third-party pricing comparisons and analyst reports
  • FDA — Medications containing semaglutide marketed for type 2 diabetes or weight loss
  • FDA — Compounding and the FDA: Questions and Answers
  • FDA — Drug Shortages database
  • DailyMed (NIH) — Wegovy, Ozempic, Zepbound, Mounjaro prescribing information
  • NEJM — STEP-1 (Wilding 2021), SELECT (Lincoff 2023), SURMOUNT-1 (Jastreboff 2022)
  • Eli Lilly investor briefings on retatrutide development pipeline (Phase 3 trials)
  • State Board of Pharmacy licensure lookups (varies by state)
  • Federation of State Medical Boards — FSMB DocInfo physician verification
  • LegitScript healthcare merchant directory (where applicable)
Important medical and regulatory disclosure Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They are not the same as Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications may be prescribed only when clinically appropriate after review by a licensed medical provider. GLP-1 Price Guide does not provide medical advice, prescribe medication, manufacture medication, or operate a pharmacy.

Frequently asked questions

What is the pharmacy directory?
It is profiles of the 503A and 503B pharmacies behind compounded GLP-1. Every page is reviewed against our published pricing methodology.
How does GLP-1 Price Guide compare providers?
We score providers on true monthly cost, pharmacy transparency, provider oversight, shipping, dose policy, and marketing honesty — not the advertised starter price.
Why does true monthly cost matter more than the starter price?
Many programs advertise a low first-month price, then charge more at maintenance dose or add membership and shipping fees. True monthly cost reflects what you actually pay long term.
Are compounded GLP-1 medications FDA-approved?
Compounded semaglutide and compounded tirzepatide are not FDA-approved finished drug products. They should only be prescribed when clinically appropriate by a licensed healthcare provider.
How often is pricing updated?
Pricing is re-verified monthly from publicly available provider pages and dated third-party sources, and labeled with a confidence status.

Related pricing tools & guides